Atara Biotherapeutics, Inc.

Biotechnology • Healthcare • Thousand Oaks, CA, United States • ATRA (NMS)

Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) with post-transplant lymphoproliferative disease, as well as other EBV-driven diseases. The company has research collaboration agreements with Memorial Sloan Kettering Cancer Center, and Council of the Queensland Institute of Medical Research. Atara Biotherapeutics, Inc. was incorporated in 2012 and is headquartered in Thousand Oaks, California.

Stock Performance (90 Days)

Data through Dec 23, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Atara Biotherapeutics (ATRA) Soars 10.0%: Is Further Upside Left in the Stock? - Yahoo Finance

Yahoo Finance • Sep 25

Pierre Fabre Pharmaceuticals Announces Transfer from Atara Biotherapeutics of the Biologics License Application (BLA) for Tabelecleucel as Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) - PR Newswire

PR Newswire • Nov 3

Atara Biotherapeutics: An Empty Pipeline With Little Gas (NASDAQ:ATRA) - Seeking Alpha

Seeking Alpha • Nov 30

Atara Biotherapeutics Announces Third Quarter Financial Results and Operational Progress - Business Wire

Business Wire • Nov 12

Atara Biotherapeutics (ATRA) Price Target Increased by 15.69% to 20.06 - Nasdaq

Nasdaq • Dec 21

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Atara Biotherapeutics, Inc. had layoffs?

No layoff events have been recorded for Atara Biotherapeutics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Atara Biotherapeutics, Inc. have?

Atara Biotherapeutics, Inc. has approximately 38 employees.

What industry is Atara Biotherapeutics, Inc. in?

Atara Biotherapeutics, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Atara Biotherapeutics, Inc. a publicly traded company?

Yes, Atara Biotherapeutics, Inc. is publicly traded under the ticker symbol ATRA on the NMS. The company has a market capitalization of approximately $0.13 billion.

Where is Atara Biotherapeutics, Inc. headquartered?

Atara Biotherapeutics, Inc. is headquartered in Thousand Oaks, CA, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.